Results 261 to 270 of about 132,395 (346)

Antibody-based therapeutics and therapeutic development for diabetic retinopathy: targeting VEGF, Ang/Tie, and inflammatory pathways. [PDF]

Front Endocrinol (Lausanne)
Zong Y, Qiu S, Zhang H, Wu J, Du J, Kamoi K, Cen Z.   +6 more
europepmc   +1 more source

Optimizing pre-injection preparation to reduce endophthalmitis after intravitreal injection

, 2020
Farzad Jamshidi, Michelle C. Callegan, Vinay Shah, Sun Young Lee   +3 more
openalex   +1 more source

Safety outcomes of a mobile laminar airflow device to perform intravitreal injections: a 3-year retrospective study [PDF]

Matteo Mario Carlà, Alessandra Scampoli, Lorenzo Governatori, Giulia Grieco, Roberta Catalani, Walter Calcatelli, Tomaso Caporossi   +6 more
openalex   +1 more source

Protective Effect of Intravitreal Administration of Exosomes Derived from Mesenchymal Stem Cells on Retinal Ischemia

Current Eye Research, 2017
E. Moisseiev, Johnathon D. Anderson, S. Oltjen, Mayank Goswami, R. Zawadzki, J. Nolta, Susanna S. Park   +6 more
semanticscholar   +1 more source

Efficacy of faricimab for recalcitrant multifactorial cystoid macular edema. [PDF]

Am J Ophthalmol Case Rep
Hanson J, Yamamoto M, Tsui E, Tsui I.
europepmc   +1 more source

Re: Israilevich et al.: Risk of endophthalmitis based on cumulative number of anti-VEGF intravitreal injections (Ophthalmology. 2024;131:667–673) [PDF]

Yohei Hashimoto
openalex   +1 more source

Intravitreal Dexamethasone Implant in Retinal Vein Occlusion: A Pilot Study Exploring Baseline Ocular and Circulating Biomarkers. [PDF]

Int J Mol Sci
Gesualdo C, Rossi S, D'Agostino FA, Casaburi R, Trotta MC, Lepre CC, Russo M, D'Amico M, Simonelli F.   +8 more
europepmc   +1 more source

Intravitreal Fluocinolone Acetonide and Intraocular Pressure: 1 year of follow-up in a clinical setting

, 2017
Ana Carolina Abreu, João Coelho, Bernardete Pessoa, Maria João Menéres, Angelina Meireles   +4 more
openalex   +1 more source

Review of: "Incidence and Predictors of Ocular Hypertension After Intravitreal Injection of Bevacizumab Among Patients Attending KCMC Hospital, 2023–2024" [PDF]

Jonas Michel Wolf
openalex   +1 more source